Evidence map›Paper›PMID 27624124›Full record

ArticlemBio2016

Not a Simple Tether: Binding of Toxoplasma gondii AMA1 to RON2 during Invasion Protects AMA1 from Rhomboid-Mediated Cleavage and Leads to Dephosphorylation of Its Cytosolic Tail.

Shruthi Krishnamurthy, Bin Deng, Roxana Del Rio, Kerry R Buchholz, Moritz Treeck, Siniša Urban, John Boothroyd, Ying-Wai Lam, Gary E Ward

Open access · goldAbstract read
In one paragraph

Article in mBio, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.6field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Malaria: past, present, and future.Signal transduction and targeted therapy · 2025
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Pathogens (Basel, Switzerland) · 2020
    Article
  9. iTRAQ-Based Phosphoproteomic Analysis ofFrontiers in cellular and infection microbiology · 2020
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Frontiers in cellular and infection microbiology · 2018
    Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Shruthi KrishnamurthyDepartment of Microbiology and Molecular Genetics, University of Vermont, Burlington, Vermont, USA.
Bin DengDepartment of Biology, University of Vermont, Burlington, Vermont, USA Vermont Genetics Network Proteomics Facility, University of Vermont, Burlington, Vermont, USA.
Roxana Del RioDepartment of Medicine, University of Vermont, Burlington, Vermont, USA.
Kerry R BuchholzDepartment of Microbiology and Immunology, Stanford School of Medicine, Stanford, California, USA.
Moritz TreeckDepartment of Microbiology and Immunology, Stanford School of Medicine, Stanford, California, USA.
Siniša UrbanDepartment of Molecular Biology and Genetics, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
John BoothroydDepartment of Microbiology and Immunology, Stanford School of Medicine, Stanford, California, USA.
Ying-Wai LamDepartment of Biology, University of Vermont, Burlington, Vermont, USA Vermont Genetics Network Proteomics Facility, University of Vermont, Burlington, Vermont, USA.
Gary E WardDepartment of Microbiology and Molecular Genetics, University of Vermont, Burlington, Vermont, USA Gary.Ward@uvm.edu.
Stanford Medicine · USUniversity of Vermont · USVermont Oxford Network · USJohns Hopkins Medicine · US

Funding

Vermont INBRE Administrative Supplement 2024 AWD 118P20GM103449 · NIGMS · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI CHRISTOPHER S FRANCKLYN · 2012 to 2026
$58.4M
Vermont Immunobioloigy/ Infectious Diseases CenterP20GM103496 · NIGMS · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI BUDD, RALPH C · 2012 to 2015
$8.7M
Toxoplasma Rhoptry FunctionR01AI021423 · NIAID · STANFORD UNIVERSITY · PI BOOTHROYD, JOHN C · 1985 to 2018
$7.8M
Vermont Immunology/Infectious Diseases CenterP30GM118228 · NIGMS · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI BUDD, RALPH C · 2016 to 2021
$6.8M
Biochemistry of Intramembrane Proteases From PathogensR01AI066025 · NIAID · JOHNS HOPKINS UNIVERSITY · PI NATHANS, JEREMY · 2005 to 2019
$4.9M
Functional Analysis of the T. gondii AMA1 Cytosolic TailR01AI105191 · NIAID · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI WARD, GARY E · 2014 to 2018
$1.9M
ANTIGENS OF TOXOPLASMA GONDII AND THEIR GENESR37AI021423 · NIAID · STANFORD UNIVERSITY · PI BOOTHROYD, JOHN C · 1994 to 2003
$1.6M
Catalysis In the Membrane: Developing Direct Assays for High-Throughput ScreeningR01AI110925 · NIAID · JOHNS HOPKINS UNIVERSITY · PI URBAN, SINISA · 2015 to 2017
$1.2M
Phosphoproteome of ToxoplasmaR21AI097633 · NIAID · STANFORD UNIVERSITY · PI BOOTHROYD, JOHN C · 2012 to 2013
$430k
NIAID NIH HHS R01 AI021423NIAID NIH HHS R01 AI066025NIAID NIH HHS R01 AI105191NIAID NIH HHS R01 AI110925NIAID NIH HHS R21 AI097633NIAID NIH HHS R37 AI021423NIGMS NIH HHS P20 GM103449NIGMS NIH HHS P20 GM103496NIGMS NIH HHS P30 GM118228
6 · The paper itself

Abstract

unlabelledApical membrane antigen 1 (AMA1) is a receptor protein on the surface of Toxoplasma gondii that plays a critical role in host cell invasion. The ligand to which T gondii AMA1 (TgAMA1) binds, TgRON2, is secreted into the host cell membrane by the parasite during the early stages of invasion. The TgAMA1-TgRON2 complex forms the core of the "moving junction," a ring-shaped zone of tight contact between the parasite and host cell membranes, through which the parasite pushes itself during invasion. Paradoxically, the parasite also expresses rhomboid proteases that constitutively cleave the TgAMA1 transmembrane domain. How can TgAMA1 function effectively in host cell binding if its extracellular domain is constantly shed from the parasite surface? We show here that when TgAMA1 binds the domain 3 (D3) peptide of TgRON2, its susceptibility to cleavage by rhomboid protease(s) is greatly reduced. This likely serves to maintain parasite-host cell binding at the moving junction, a hypothesis supported by data showing that parasites expressing a hypercleavable version of TgAMA1 invade less efficiently than wild-type parasites do. Treatment of parasites with the D3 peptide was also found to reduce phosphorylation of S527 on the cytoplasmic tail of TgAMA1, and parasites expressing a phosphomimetic S527D allele of TgAMA1 showed an invasion defect. Taken together, these data suggest that TgAMA1-TgRON2 interaction at the moving junction protects TgAMA1 molecules that are actively engaged in host cell penetration from rhomboid-mediated cleavage and generates an outside-in signal that leads to dephosphorylation of the TgAMA1 cytosolic tail. Both of these effects are required for maximally efficient host cell invasion. IMPORTANCE: Nearly one-third of the world's population is infected with the protozoan parasite Toxoplasma gondii, which causes life-threatening disease in neonates and immunocompromised individuals. T. gondii is a member of the phylum Apicomplexa, which includes many other parasites of veterinary and medical importance, such as those that cause coccidiosis, babesiosis, and malaria. Apicomplexan parasites grow within their hosts through repeated cycles of host cell invasion, parasite replication, and host cell lysis. Parasites that cannot invade host cells cannot survive or cause disease. AMA1 is a highly conserved protein on the surface of apicomplexan parasites that is known to be important for invasion, and the work presented here reveals new and unexpected insights into AMA1 function. A more complete understanding of the role of AMA1 in invasion may ultimately contribute to the development of new chemotherapeutics designed to disrupt AMA1 function and invasion-related signaling in this important group of human pathogens.

Indexed as

Protein Processing, Post-TranslationalProteolysisAntigens, ProtozoanCells, CulturedFibroblastsHumansPeptide HydrolasesPhosphorylationProtein BindingProtozoan ProteinsToxoplasmaAMA1 protein, Toxoplasma gondiiAntigens, ProtozoanPeptide HydrolasesProtozoan Proteinsrhoptry neck protein 2, Toxoplasma gondii

Identifiers

PMID27624124
PMCPMC5021801
OpenAlexW2520219491

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.